Manufacture of oils and fats
GRØNTVEDT BIOTECH AS
Revenue 2024
NOK 8.1m
Operating profit
NOK −9.8m
Equity
NOK −12.7m
Incorporated
2022
Share capital
NOK 1.0m
Key figures · 2024
Current ratio
0.30
Equity ratio
-126.5%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -121.6% | |
| Net margin (%%) | -169.6% | |
| Return on assets (%%) | -98.3% | |
| Likviditet | ||
| Current ratio | 0.30 | |
| Working capital | −15.8m | |
| Soliditet | ||
| Equity ratio (%%) | -126.5% | |
| Debt-to-equity ratio | -1.79 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.